Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Income from Continuing Operations: 2023-2025

Historic Income from Continuing Operations for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$33.7 million.

  • Upstream Bio's Income from Continuing Operations fell 110.95% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 113.52%. This contributed to the annual value of -$65.6 million for FY2024, which is 82.59% down from last year.
  • According to the latest figures from Q3 2025, Upstream Bio's Income from Continuing Operations is -$33.7 million, which was up 15.50% from -$39.9 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Income from Continuing Operations peaked at -$7.9 million during Q3 2023, and registered a low of -$39.9 million during Q2 2025.
  • Over the past 3 years, Upstream Bio's median Income from Continuing Operations value was -$16.0 million (recorded in 2024), while the average stood at -$20.8 million.
  • Data for Upstream Bio's Income from Continuing Operations shows a maximum YoY crashed of 172.22% (in 2025) over the last 5 years.
  • Quarterly analysis of 3 years shows Upstream Bio's Income from Continuing Operations stood at -$12.8 million in 2023, then crashed by 65.81% to -$21.2 million in 2024, then crashed by 110.95% to -$33.7 million in 2025.
  • Its last three reported values are -$33.7 million in Q3 2025, -$39.9 million for Q2 2025, and -$27.3 million during Q1 2025.